BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 10853036)

  • 21. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
    Au A; Li B; Wang W; Roy H; Koehler K; Birt D
    Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate.
    Chung FL; Conaway CC; Rao CV; Reddy BS
    Carcinogenesis; 2000 Dec; 21(12):2287-91. PubMed ID: 11133820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
    Janakiram NB; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon.
    Rao CV; Simi B; Reddy BS
    Carcinogenesis; 1993 Nov; 14(11):2219-25. PubMed ID: 8242846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
    Magnuson BA; Bird RP
    Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
    Momen MA; Monden Y; Houchi H; Umemoto A
    J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
    Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
    Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.
    Sekine K; Watanabe E; Nakamura J; Takasuka N; Kim DJ; Asamoto M; Krutovskikh V; Baba-Toriyama H; Ota T; Moore MA; Masuda M; Sugimoto H; Nishino H; Kakizoe T; Tsuda H
    Jpn J Cancer Res; 1997 Jun; 88(6):523-6. PubMed ID: 9263527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats.
    Verghese M; Rao DR; Chawan CB; Williams LL; Shackelford L
    J Nutr; 2002 Sep; 132(9):2809-13. PubMed ID: 12221250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats.
    Nozawa H; Yoshida A; Tajima O; Katayama M; Sonobe H; Wakabayashi K; Kondo K
    Int J Cancer; 2004 Jan; 108(3):404-11. PubMed ID: 14648707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).
    Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND
    Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
    Kawamori T; Takahashi M; Watanabe K; Ohta T; Nakatsugi S; Sugimura T; Wakabayashi K
    Cancer Lett; 2000 Jan; 148(1):33-7. PubMed ID: 10680590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.
    Kawamori T; Tanaka T; Hirose Y; Satoh K; Hara A; Torihara M; Tamai Y; Yamahara J; Mori H
    Cancer Lett; 1995 Jun; 92(2):159-65. PubMed ID: 7600526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells.
    Patlolla JM; Raju J; Swamy MV; Rao CV
    Mol Cancer Ther; 2006 Jun; 5(6):1459-66. PubMed ID: 16818504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats.
    Onogi N; Okuno M; Komaki C; Moriwaki H; Kawamori T; Tanaka T; Mori H; Muto Y
    Carcinogenesis; 1996 Jun; 17(6):1291-6. PubMed ID: 8681445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
    Ishikawa S; Asano T; Takenoshita S; Nozawa Y; Arihara K; Itoh M
    Nutr Res; 2009 Jan; 29(1):64-9. PubMed ID: 19185779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon.
    Luceri C; Caderni G; Lancioni L; Aiolli S; Dolara P; Mastrandrea V; Scardazza F; Morozzi G
    Nutr Cancer; 1996; 25(2):187-96. PubMed ID: 8710688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Yasui Y; Suzuki R; Kohno H; Miyamoto S; Beppu F; Hosokawa M; Miyashita K; Tanaka T
    Nutr Cancer; 2007; 59(1):82-91. PubMed ID: 17927506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.